AC
Anirban Chatterjee
About Anirban Chatterjee
Data last updated:
Anirban Chatterjee is a Director at Prospect Pharmaceuticals Private Limited (since 2017), Director at Spasibo Enterprise Private Limited (since 2018) and Designated Partner at Tripti Pharmacy Llp (since 2025), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.69 Cr; the largest is Prospect Pharmaceuticals Private Limited at ₹14.78 Cr (FY 2024). Earlier, Anirban Chatterjee was a Director at Endeavor Pharmaceuticals Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Prospect Pharmaceuticals Private Limited U51909WB2017PTC221360 | Director | 05 Jun 2017 | 2017 | ₹14.78 Cr (FY 2024) | Active |
| Spasibo Enterprise Private Limited U51909WB2018PTC228980 | Director | 27 Nov 2018 | 2018 | ₹7.90 Cr (FY 2025) | Active |
| Tripti Pharmacy Llp ACP-0445 | Designated Partner | 11 Jun 2025 | 2025 | Active | |
| Anirsang Enterprise Private Limited U46497WB2025PTC280103 | Director | 05 Jun 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Endeavor Pharmaceuticals Private Limited U51909WB2017PTC219059 | Director | 24 Jan 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anirban Chatterjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sangeeta Das | 07754327 | Prospect Pharmaceuticals Private Limited , Spasibo Enterprise Private Limited and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anirban Chatterjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anirban Chatterjee
Anirban Chatterjee currently holds 4 directorships: Prospect Pharmaceuticals Private Limited (Director, since 05 Jun 2017, revenue ₹14.78 Cr (FY 2024)); Spasibo Enterprise Private Limited (Director, since 27 Nov 2018, revenue ₹7.90 Cr (FY 2025)); Tripti Pharmacy Llp (Designated Partner, since 11 Jun 2025); Anirsang Enterprise Private Limited (Director, since 05 Jun 2025).
Anirban Chatterjee was first appointed on 24 Jan 2017 as Director at Endeavor Pharmaceuticals Private Limited. The most recent appointment on record is 11 Jun 2025 at Tripti Pharmacy Llp.
The 2 current companies of Anirban Chatterjee that report revenue have a combined latest revenue of ₹22.69 Cr: Prospect Pharmaceuticals Private Limited ₹14.78 Cr (FY 2024); Spasibo Enterprise Private Limited ₹7.90 Cr (FY 2025).
Anirban Chatterjee held 1 earlier board appointment: Endeavor Pharmaceuticals Private Limited (Director, from 24 Jan 2017).
The current boards of Anirban Chatterjee's companies include Sangeeta Das (Prospect Pharmaceuticals Private Limited).